The world’s largest biotechnology conference – BIO International 2016 – will be held in June at San Francisco’s Moscone Convention Center. New Jersey will be strongly represented there by a delegation of more than 20 New Jersey companies, universities and state government.
“New Jersey has many assets that make it attractive for biotech companies, and BIO International provides the ideal venue to showcase them,” says Michele Brown, president and CEO of Choose New Jersey. “We have the world’s highest concentration of talent in commercialization and R&D. Our location and resources for life sciences companies are among the best in the country. We look forward to a very productive week at BIO.”
Choose New Jersey is partnering with BioNJ, the New Jersey Business Action Center (BAC) and the New Jersey Economic Development Authority (NJEDA) to sponsor a 1,500-square-foot New Jersey Pavilion at the Center. Companies represented in the Pavilion will include: Ferring Pharmaceuticals; Novartis Pharmaceuticals; Amicus Therapeutics; Bell Works; BLS & Co.; Cepter Biopartners; Helsinn; Janssen Pharmaceutical Companies of Johnson & Johnson; Sills Cummis & Gross; Vivo Bio Tech Ltd.; and Zoetis.
Showcasing New Jersey’s hospitals and universities will be: Hackensack University Medical Center (HackensackUMC); New Jersey Institute of Technology (NJIT); Princeton University; Rowan University; Stevens Institute of Technology; and, Rutgers, The State University of New Jersey.
“We’re eager to showcase New Jersey’s dynamic life sciences ecosystem, including the unprecedented innovation coming from the state – with an unparalleled talent pool,” says Debbie Hart, president and CEO, BioNJ.
Choose New Jersey, the HealthCare Institute of New Jersey (HINJ), New Brunswick Development Corporation (DEVCO) and Jones Lang LaSalle (JLL) also are sponsoring a by-invitation-only reception dinner where they will discuss the strategic advantages of a New Jersey location with a select group of company decision makers. Last year’s dinner was attended by more than 100 guests, including more than 50 executives considering a move to New Jersey.
“HINJ is pleased to partner again with Choose New Jersey in its efforts to promote the state’s world-class life sciences innovation ecosystem as the lead sponsor of its reception at the BIO International Convention,” says Dean J. Paranicas, president and CEO, HINJ.
Choose New Jersey, BAC and EDA also have scheduled private business meetings with company executives interested in exploring a New Jersey location.
BIO International attracts more than 15,800 attendees representing nearly 50 states, 70 countries, plus 1,800 exhibitors and pavilions annually.
Choose New Jersey
President and CEO
Princeton, NJ 08560